Your browser doesn't support javascript.
loading
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival.
Kasuga, Akiyoshi; Okano, Naohiro; Naruge, Daisuke; Kitamura, Hiroshi; Takasu, Atsuko; Nagashima, Fumio; Furuse, Junji.
Afiliación
  • Kasuga A; Department of Medical Oncology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-City, Tokyo, 181-1611, Japan, akiyoshi_81@hotmail.com.
Cancer Chemother Pharmacol ; 75(3): 457-64, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25547407

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Inflamación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Inflamación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2015 Tipo del documento: Article